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Tinospora cordifolia plant and its various bioactive components have wide range of pharmacological properties. Aqueous extract 
of Tinospora cordifolia stem and arabinogalactan (AG), its bioactive polysaccharide, act as anti-cancer agents and have the 
potential for preparation of new drugs against lung cancer.
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Introduction: Aqueous Tinospora cordifolia stem extract (Aq.Tc) and arabinogalactan (AG), 
its bioactive polysaccharide, which are antioxidant remedies were evaluated on pulmonary 
cancer and associated tumor markers.
Methods: Mice were randomly segregated into 6 groups. Group I: animals served as control. 
Group II: animals which were administered Aq.Tc extract (200 mg/kg, orally), thrice a week. 
Group III: animals which received AG (7.5 mg/kg, orally) thrice a week. Group IV: animals 
which were instilled with benzo(a)pyrene (B(a)P) (50 mg/kg, orally) twice within an interval 
of 2 weeks. Group V: animals which received Aq.Tc extract as in group II, along with B(a)P 
after 2 weeks of Aq.Tc administration. Group VI: animals which received AG as in group III 
along with B(a)P after 2 weeks of AG administration.
Results: As expected, B(a)P treated mice exhibited high tumor incidence and multiplicity 
with concomitant increase in serum/plasma markers like carcinoembryonic antigen (CEA), 
circulating tumor DNA (ctDNA), lactate dehydrogenase (LDH) and tumor necrosis factor. 
However, Aq.Tc and AG supplementation to B(a)P abused animals significantly attenuated 
these parameters at different stages of cancer, depicting their anti-cancer effects in lung 
carcinogenesis. Also, treatment of Aq.Tc and AG to tumor bearing mice reduced the degree 
of histopathological alterations as compared to B(a)P installed mice. The apoptotic index 
in case of Aq.Tc and AG fed mice treated with B(a)P was higher as compared to only B(a)P 
treated mice. Further it was observed that Aq.Tc could induce higher degree of apoptosis when 
compared to AG group, suggesting Aq.Tc as a more effective modulator of tumorigenesis.
Conclusion: Overall, these findings substantiate the chemopreventive potential of Aq.Tc and 
AG against lung tumorigenesis. Aq.Tc was found to be more effective than AG in modulating 
the process of lung carcinogenesis as reflected by various observations.
A R T I C L E  I N F O
Keywords:
Arabinogalactan
Benzo(a)pyrene
Lactate dehydrogenase
Medicinal plant
Tinospora cordifolia
Article History:
Received: 10 January 2018 
Accepted: 20 June 2018
Article Type:
Original Article
A B S T R A C T
Introduction
Lung cancer is the prime cause of cancer mortality and 
is a growing economic burden worldwide (1). Primary 
factors that lead to induction of lung cancer include use of 
tobacco, automobile exhausts, occupational exposure and 
indoor air pollution (2). Polycyclic aromatic hydrocarbons 
(PAHs) are the major constituents of these pollutants 
(3). One of the most potent PAH, Benzo(a)pyrene {B(a)
P} is known to induce lung cancer in humans as well as 
experimental animals (4). 
In spite of various advancements in lung cancer 
diagnosis and treatment, survival rates remain low (5). 
Generally, tumor size and its extent of invasion detected 
histopathologically (biopsy) is considered to be the gold 
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standard for evaluating the disease (6). Since the procedure 
of biopsy is invasive and could add to the agony of the 
patient, different serological markers of tumor could be 
taken into account for specific diagnosis and evaluation 
of progress of cancer (7). Sensitive and specific diagnostic 
markers of lung cancer could facilitate the early detection 
of the cancer lowering the associated mortality rates (8). 
Various serum markers include circulating tumor DNA 
(ctDNA), carcinoembryonic antigen (CEA), neuron 
specific enolase (NSE), carbohydrate antigen 125 (CA125) 
and squamous cell carcinoma antigen (SCC) (9). These 
markers when combined with other diagnostic tools 
could classify tumor into different molecular subtypes and 
monitor disease relapse and treatment response (10).
Since, there is no magic bullet to combat cancer, lung 
cancer is no exception to it, never the less, the risk 
could be reduced by eliminating contact or exposure 
to putative carcinogens. But this may not be feasible 
always, considering the quality of air, soil and water in 
the present scenario. Therefore, it presses the need for 
adopting other practical measures to control the dreadful 
disease. The complexity of this hyperproliferative disease 
necessitates the adoption of secondary prevention as a 
rational way to control it (11). The use of botanicals in the 
form of vegetables, fruits and other dietary supplements 
as chemopreventive agents seem to be relevant (12). 
Chemoprevention is a reasonable and cost-effective 
approach to decrease cancer mortality by inhibiting the 
pre-cancerous events and/or delaying its progression (13). 
Most of the drugs that are available to combat cancer have 
shown severe side effects. Synthetic chemopreventive 
drugs are cytotoxic, immune suppressants and may cause 
a variety of ill effects in various organs of the body (14).
Various drugs that are currently being used are based 
on folk remedies and subsequent ethnopharmacological 
studies. There are more than 100 drugs of known 
structure that are extracted from medicinal plants. As 
modern medicine came up, people started looking for 
active components from the crude extract but due to 
their higher/acute side effects they are not much being 
used (15). Various medicinal plants have been identified 
for their anticancer properties and in varied number of 
ailments (16,17). Tinospora cordifolia is a known medicinal 
plant having a wide spectrum of pharmacological activity. 
It is commonly known as ‘Guduchi’ or ‘Amrita’ and is 
considered as an important drug of Indian Systems of 
Medicine (18). Different parts of this plant including 
leaves, roots and stem have been widely used for their 
variety of medicinal properties (19). However, use of 
stem has been widely reported, so far (20). T. cordifolia 
is known to exhibit anti-inflammatory and anti-cancer 
properties in various experimental models (21). There 
are several experimental reports which document the 
anticancer potential of aqueous, methanolic as well as 
ethanolic extracts of T. cordifolia in various cancer models 
(22,23). One of the active constituents in its polysaccharide 
fraction is arabinogalactan (AG) (24). Its potent biological 
activity and immune-enhancing properties have received 
increased attention as a clinically useful nutraceutical 
agent (25). AG has several properties which make it an 
ideal adjunct supplement to be considered in cancer 
protocols (26). 
Aqueous extract of T. cordifolia is enriched in the 
polysaccharide fraction containing AG when compared 
with other types of extract (27). Many biological activities 
of T. cordifolia have been attributed to its polysaccharide 
fraction (28). The above mentioned observations warrant 
further investigations with respect to preparations rich in 
AG or its use as such active principle. 
The polysaccharide fraction of T. cordifolia in lung has 
shown profound anti-metastatic activity against lung 
cancer cell lines (29). However, not much has been 
explored about its effect in in vivo lung cancer models and 
the underlying mechanism involved. Considering this, the 
present study was designed to assess the effects of aqueous 
T. cordifolia extract and its bioactive polysaccharide AG in 
in vivo benzo(a)pyrene induced pulmonary carcinogenesis 
model.
Material and Methods
Chemicals and kits
1,1-diphenyl 2-picrylhydrazyl (DPPH), 2,2’-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) (ABTS), Benzo(a)
pyrene (B(a)P) and AG (99% pure) were obtained from 
Sigma-Aldrich Co. (St. Louis, MO, USA). Rest of the 
chemicals used were of analytical grade. Terminal 
deoxynucleotidyl transferase dUTP nick end labelling 
(TUNEL) assay kit was procured from Trevigen Inc. 
(Gaithersburg, Maryland, USA). FitAmpTM Circulating 
DNA Quantification kit was procured from Epigenetek 
(Farmingdale, New York, USA).
Preparation of aqueous Tinospora cordifolia stem extract
Tinospora cordifolia stems were collected from the Panjab 
University Botanical Garden after identification by a 
qualified Botanist. Aqueous powder of T. cordifolia was 
prepared according to method described by Tiwari et al, 
with minor modifications (30,31). Dried Aq. Tc powder 
(500 mg) was reconstituted in 10 mL of distilled water and 
was subjected to preliminary screening for the presence of 
phytoconstituents by standard protocol (32).
Free radical scavenging activity assays
Free radical scavenging activity of Aq.Tc as well as AG was 
analysed using DPPH (1,1-diphenyl 2-picrylhydrazyl) 
radical scavenging assay (33) and ABTS radical cation 
(ABTS·+) assay (34). 
Animals and experimental conditions
Male Balb/c mice (25–30 g) were procured from the Central 
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Animal House, Panjab University, Chandigarh (Approval 
no PU/IAEC/S/15/61 Panjab University, Chandigarh). 
Mice were housed in polypropylene cages bedded with 
sterilized rice husk and were provided with standard pellet 
diet (Ashirwad Industries Ltd., Ropar, Punjab, India) and 
water ad libitum with standard conditions of relative 
humidity (50%–60%) and temperature (24±2°C). Mice 
were acclimatized to the experimental conditions for one 
week after which various treatments were given.
Experimental design
Mice were randomly segregated into 6 groups (n=6-
8). Group I animals served as control and received no 
special treatment. Group II animals were administered 
aqueous T. cordifolia extract (Aq.Tc) (200 mg/kg, orally) 
on the alternate days (thrice a week). Group III animals 
were administered AG (7.5 mg/kg, orally) on alternate 
days (thrice a week). Group IV animals were instilled 
with B(a)P (50 mg/kg, i.p.) twice, within an interval of 
two weeks. Group V animals received Aq.Tc extract as 
in group II, along with B(a)P was installed after 2 weeks 
of Aq.Tc administration following the same protocol as 
for group IV. Group VI animals received AG as in group 
III along with B(a)P was instilled after 2 weeks of AG 
administration following the same protocol as in group 
IV. Changes in body weight, diet and water intake were 
observed every week in all the groups throughout the 
treatment period. Dose of Aq.Tc in the present study was 
standardized according to the available literature (200 mg/
kg) (35). Dose of AG was deduced considering the amount 
of AG (active polysaccharide) present in 200 mg of Aq.Tc 
which amounted to 7.5 mg/kg (Figure 1A).
Tumor assessment studies
Tumor statistics
At the end of the treatment period (22 weeks), the lung 
tissue/lung tumors were excised and analyzed for (a) 
tumor incidence (b) tumor size (c) tumor multiplicity 
following the protocol of Gupta et al (36).
Histopathological evaluation
Lung tissue/tumors were excised at the end of 10th and 
22nd weeks, fixed in 10% formaldehyde in phosphate 
buffer saline (pH 7.4) for Haematoxylin and eosin (H&E) 
staining as per the conventional laboratory procedures 
(37). H&E stained slides were evaluated under light 
Figure 1. (A) Animal treatment schedule to study the effect of Aq.Tc and AG in B(a)P induced pulmonary carcinogenesis. (B) Alterations 
in average body weight of the animals during the treatment period. Data were represented as Mean ± S.D. (n=6-10)
(A) (A)
(B)
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microscope (LEICA DM 3000).
Tumor markers
Various tumor markers were estimated in the plasma/
serum of mice from different treatment groups. Blood 
samples from the mice of various treatment groups were 
collected by retro-orbital puncture. Prior to retro-orbital 
puncture, a drop of 0.5% pro-paracaine hydrochloride 
ophthalmic solution (Sunways Pvt. Ltd. India) was applied 
to anesthetize the eyes so that pain was reduced.
Carcinoembryonic antigen 
Quantification of tumor marker CEA was estimated 
in blood serum using the Qayee-Bio Mouse 
carcinoembryonic antigen ELISA kit. The detection range 
of the kit lies between 78 pg/mL to 5000 pg/mL.
Circulating tumor DNA 
Circulating tumor DNA was quantified using the 
FitAmp™ Circulating DNA Quantification kit for mouse. 
The linear detection range of the kit lies between 0.1 ng 
to 100 ng (1-1000 ng/mL) in 96-well plate assay. DNA 
was fluorescently quantified at Ex 480-500 and Em 520-
550 nm using a fluorescence microplate reader (Biotek 
Synergy H1 microplate reader).
Lactate dehydrogenase 
The specific activity of Lactate dehydrogenase (LDH) 
in blood serum was estimated according to the method 
described by Bergmeyer and Bernt (38) using molar 
extinction coefficient 6.22 mM-1cm-1.
Quantification of tumor necrosis factor-alpha
Quantitative estimation of tumor necrosis factor-α 
(TNF-α) in blood serum samples of various treatment 
groups was carried out by using in vitro enzyme linked 
immunosorbent assay (ELISA) (Ray Biotech). The 
minimum detectable dose of mouse TNF-α is 30 pg/ml.
TUNEL assay
The TUNEL assay was performed on deparaffinised and 
rehydrated lung sections with the TACS-XL DAB in situ 
apoptosis detection kit according to the manufacturer’s 
specifications. Apoptotic index was calculated as the 
percentage of TUNEL (+ve) cells were quantified over the 
total number of cells in the selected lung tissue section. 
Statistical analysis
The data were represented as mean ± standard deviation 
(SD). and analysed by one-way ANOWA followed by LSD 
post hoc test using the SPSS software package (version 16) 
for windows (SPSS Inc., Chicago, IL).
Results
Phytochemical screening
In the present study, preliminary phytochemical analysis 
Figure 2. (A) Radical scavenging effects of Aq.Tc. Extract and AG 
on ABTS radicals. (B) Radical scavenging effects of Aq.Tc. extract 
and AG on DPPH radicals. Data were represented as mean ± SD 
(n = 3).
of Aq.Tc stem extract showed the presence of alkaloids, 
phenols, flavonoids, carbohydrates, and proteins. 
However, steroids were found to be absent in the extract.
Free radical scavenging activity
In DPPH and ABTS free radical scavenging assay Aq.Tc 
extract exhibited free radical scavenging activity in a 
concentration dependent manner when compared with 
other strong antioxidants like BHT and tannic acid 
(Figure 2A and 2B). It showed a higher antiradical activity 
with IC50 of 432 µg and 49.8 µg in DPPH and ABTS assays, 
respectively. However, AG showed a greater antiradical 
activity at higher concentrations when compared with 
Aq.Tc, BHT and tannic acid. The IC50 of AG was found 
to be 648 µg and 384.17 µg in DPPH and ABTS assay, 
respectively (Table 1).
Body status, diet and water intake
Mice in all the experimental groups did not show any 
significant change in the diet and water consumption 
throughout the treatment period. A considerable decrease 
in the body weight of animals in B(a)P group was observed 
when compared with their control counterparts. There 
was no significant difference in the body growth patterns 
in animals treated with Aq.Tc and AG i.e., Aq.Tc, AG, B(a)
P + Aq.Tc and B(a)P + AG group when compared with 
control group (Figure 1B).
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Morphological changes in lung/lung tumors
Normal architecture was observed in Aq.Tc and AG treated 
lung when compared with control animals (Figure 3A). 
However, in B(a)P challenged mice lung, large number 
of superficial lesions and hematomas were observed. 
Prominent tumor nodules around different lobes of lung 
were also present (Figure 3B). Mice bearing tumors co-
administered with Aq.Tc and AG showed a significant 
reduction in tumor nodules and tumor mass (Figure 3C, 
D, E and F, respectively).
Tumor statistics
After 22 weeks of the B(a)P treatment, the mice from B(a)
P, B(a)P +Aq.Tc and B(a)P + AG group developed lung 
tumors, whereas no tumor/lesion was observed in control, 
Aq.Tc and AG group.
The total number of tumors/lesions formed in various 
experimental groups and the associated parameters are 
summarised in Table 2.
Histopathology
Tenth week of B(a)P treatment showed loss of normal 
pulmonary architecture and higher number of hyper 
chromatic nuclei with air space enlargement (Figure 4B). 
However, in animals from B(a)P +Aq.Tc and B(a)P+AG 
groups showed decreased number of hyperchromatic 
irregular cells in the alveolar wall at 10th week of 
treatment (Figure 4D-F). Histopathological changes in 
the pulmonary tissue at 22nd week post instillation of B(a)
P revealed extensive proliferation of alveolar epithelium, 
large number of eosinophilic macrophages infiltrating 
the pulmonary parenchyma with more number of hyper 
chromatic nuclei in the alveolar wall (Figure 5B). Number 
of hyperproliferative cells in B(a)P + Aq.Tc and B(a)P + 
AG group decreased when compared to B(a)P group at 
Table 1. IC50 values of Aq.Tc. extract, AG, BHT and tannic acid using 
ABTS and DPPH scavenging activity
Extract/
Compound
IC50 value (µg/µL) 
ABTS assay
 IC50 values (µg/µL) 
DPPH assay
Tannic acid 
BHT
Aq.Tc
AG
14.24
49.80
180.66
384.17
103.21
282.40
432.52
648.50
Figure 3. Gross morphology of lungs in mice of different treatment 
groups. 
(A) Control, (B) Pulmonary lesions in B(a)P treated mice, (C), 
Aq.Tc, (D) B(a)P treated mice co-administered with Aq.Tc. extract, 
(E) AG, (F) B(a)P treated mice co-administered with AG. (arrow 
indicates tumor).
A
C
E F
D
B
Table 2. Effect of Aq.Tc and AG on B(a)P induced lung tumorigenesis at end of the treatment period where (n=6-10)
Parameters/Groups Control Aq.Tc AG B(a)P B(a)P+Aq.Tc B(a)P+AG
Tumor incidence (%) - - - 100% 66.6% 83.3%
Tumor multiplicity - - - 2.45±0.365 1.22±0.057 * 1.52±0.125 **
Total no of tumors - - - 96 53 71
Big tumors (>2 mm) - - - 83 44 63
Small tumors (<2 mm) - - - 13 9 8
Data is expressed as Mean±SD and are analysed by Student’s t test. 
* P ≤ 0.01, **P < 0.05 with regard to B(a)P.
22nd week of treatment (Figure 5D-F). 
Tumor markers
Carcinoembryonic antigen
Instillation of B(a)P showed a significant (P ≤ 0.001) 
increase in the CEA levels in a time dependent manner 
when compared with the rest of the groups (158±1.36 
to 288± 21.0 pg/mL). However, in B(a)P+AG group the 
increase was less intense (162 ± 6.20 to 228 ± 2.12 pg/mL). 
Interestingly, the levels of CEA in B(a)P +Aq.Tc group 
dropped from 165 ± 6.20 to 143±16.4 pg/mL (Table 3).
Circulating tumor DNA
A significant increase in ctDNA levels was observed in 
B(a)P group at different time intervals when compared 
with other respective groups (1.15 ± 0.012 to 3.28 ± 0.140 
ng/mL). However, Aq.Tc administration to the cancer 
bearing animals, significantly (P ≤ 0.001) lowered the 
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levels of ctDNA to their near normal values. Also, the 
levels of ctDNA were found to significantly (P ≤ 0.001) 
decreased in B(a)P + AG animals when compared to the 
B(a)P group (Table 3).
Lactate dehydrogenase
A significant increase in LDH activity in B(a)P group was 
observed when compared to various treatment groups 
(259 ± 54.1 to 628 ± 16.5 IU/L). However, treatment of 
Aq.Tc to the cancer bearing animals significantly (P ≤ 
0.001) restored the levels of LDH to their near normal 
values. Also, the levels of LDH were found to significantly 
(P ≤ 0.001) reduced in B(a)P+AG animals when compared 
to the B(a)P group (Table 3).
Quantification of TNF-alpha
TNF-alpha levels were significantly increased in B(a)
P group when compared to control, Tc and AG groups 
at different time intervals. Whereas, Aq.Tc treatment to 
cancer bearing animals significantly (P ≤ 0.001) restored 
the level of TNF-alpha to their near normal values. Also, 
the levels of TNF-alpha significantly decreased (P ≤ 0.001) 
Figure 4. Hematoxylin and eosin stained lung tissue at 10th week 
of treatment at 200 X. 
(A). Control mice showing normal histoarchitecture, (B)  B(a)P 
treated mice, (C) Aq.Tc treated mice, (D) B(a)P installed mice 
co-treated with Aq.Tc, (E) AG treated mice, (F) B(a)P installed 
mice co-treated with AG. SB; small bronchiole, SA; single 
squamous epithelium, AW; alveolar wall, AS; alveolar space, AD; 
Widespread alveolar destruction, N; thinning of alveolar walls, 
T; thickening of alveolar wall, IAS; increased alveolar sac, TB; 
thickened bronchiolar epithelium.
Figure 5. Haematoxylin and Eosin stained lung tissue/lung 
tumors at 200X. 
(A) Control mice showing normal histoarchitecture, (B)  B(a)P 
treated mice, (C) Aq.Tc treated mice, (D) B(a)P induced tumor 
co-treated with Aq.Tc, (E) AG treated mice,  (F) B(a)P induced 
tumor co-treated with AG. (EP: extensive proliferation of alveolar 
epithelium and presence of hyperchromatic nuclei in the alveolar 
wall; SB; small bronchiole, SA; single squamous epithelium, 
AW; alveolar wall, AS; alveolar space, AD; Widespread alveolar 
destruction, N; thinning of alveolar walls, T; thickening of alveolar 
wall, IAS; increased alveolar sac, TB; thickened bronchiolar 
epithelium, I; Inflammatory cellular infiltrations.
in B(a)P+AG animals when compared to the B(a)P group 
(Table 3).
TUNEL assay
A significant increase in the apoptotic index in B(a)P + 
Aq.Tc group was observed when compared with rest of the 
four groups i.e., control, AG, B(a)P and Aq.Tc. There was 
a significant increase in extent of apoptosis in B(a)P + AG 
group but much less than the B(a)P + Aq.Tc group (Figure 
6A,B).
Discussion
Lung and the associated respiratory system is the prime 
target of the inhaled contaminated air which include 
pollutants and carcinogens like B(a)P that have been 
established as important etiological agents in causation of 
lung cancers (39). Majority of lung cancers are diagnosed 
at late stages when the options for treatment are mostly 
palliative (40). Management of lung cancer requires 
monitoring of the tumor burden to determine the response 
to treatment and therefore, improved biomarkers are 
A
C
E F
D
B
C
E F
D
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needed (41). The present study was aimed to evaluate the 
efficacy of Aq.Tc extract and its active component, AG, in 
B(a)P induced lung tumorigenesis and to demonstrate the 
effect on various plasma/serum markers at different stages 
of pulmonary carcinogenesis.
To assess the chemopreventive efficacy of Aq.Tc/AG in in 
vivo system various parameters were studied in Balb/c mice 
pulmonary tumor model. The considerable weight loss 
observed in tumor bearing mice could be related to cancer 
cachexia, anorexia or malabsorption, which resulted in 
wasting of skeletal muscle and adipose tissue (42). Several 
studies have shown similar observations of decrease in 
body weight of animals following administration of B(a)
P (43). However, Aq.Tc and AG seem to prevent this 
alteration in body weight of lung tumor bearing mice. 
Chemopreventive response of Aq.Tc and AG administered 
animals challenged with B(a)P induced carcinogenesis was 
monitored on the basis of tumor incidence, multiplicity, 
size and gross morphology. All these parameters serve 
as a valuable reference to study the development of 
carcinogenesis in in vivo studies. Aq.Tc was successful 
in reducing the extent of carcinogenesis as depicted by 
different parameters like tumor morphology, multiplicity 
and incidence when compared to B(a)P group. Mean 
number of large and small tumors was also observed to be 
significantly altered in Aq.Tc treated animals. However, in 
B(a)P+AG mice less reduction in mean number of small 
tumors was observed but the number of large tumors 
varied, significantly. Earlier studies also supported our 
observation depicting that various plant extracts were 
successful in reducing lung adenoma incidence and 
multiplicity induced by B(a)P in mice. To the best of our 
knowledge no reports are available of chemopreventive 
effects of Aq.Tc extract and AG in in vivo lung tumor 
model.
Mode of cell death can be a useful parameter to assess the 
severity of the cancer (44). Dysregulation of apoptosis is 
pivotal to tumorigenesis and the development of most 
cancers (45). Aq.Tc treated animals bearing tumors 
revealed enhanced apoptosis in comparison to the B(a)
P treated mice bearing pulmonary tumors. Increase in 
apoptotic index may also be responsible for the decrease 
in the size of the tumors in the B(a)P+Aq.Tc group. The 
induction of apoptosis by Aq.Tc extract has already been 
documented in the literature as a potential candidate in 
therapy to glioblastomas (46). Pure active component AG 
of T. cordifolia was found to be less effective in inducing 
apoptosis in lung tumor bearing mice. Our lab also 
reported the induction of apoptosis by using different 
plant extracts in cancer models (47).
 Pro-inflammatory cytokines such as TNF-α are the 
major molecular players involved in inflammation to 
cancer axis. As a representative inflammatory cytokine 
with pleiotropic functions, TNF-α plays a dual role in 
carcinogenesis (48). In the present study, the gradual 
increased levels of TNF-α at 10th and 22nd week of 
treatment in lung cancer bearing animals may be due to 
pronounced inflammatory response and increased cell 
Table 3. Effect of Aq.Tc and AG on various blood tumor markers at different time intervals during B(a)P induced lung tumorigenesis
Parameters/Groups Weeks Control Aq.Tc AG B(a)P B(a)P+Aq.Tc B(a)P+AG
CEA (pg/ml) 0 160.5± 1.56 160.3±9.30 164.5±6.82 159.5±1.36 162.2±10.7 162.9±6.20
10 164.8± 4.54 146.8±12.9 168.1±11.73 251.1±8.64 a1b1c1 165.5±11.6 d1
205.3±11.0
c3e3
22 164.2±5.49 176.0±15.4 174±6.57 288.3±21.0a3b1c1
143.1±16.4 
d1
228.7±2.12
b2d2
ctDNA (ng/ml) 0 1.28±0.012 1.11±0.013 1.21±0.010 1.15±0.012 1.17±0.010 1.19±0.020
10 1.29±0.015 1.27±0.062 1.34±0.219 2.95±0.060 a1b1c1
1.65±0.189
a1b1c1d1
2.37±0.210
a1b1c1d2
22 1.41±0.010 1.30±0.010 1.31±0.005 3.28±0.140a1b1c1
2.33±0.100
d1
2.52±0.136
a1b1c1d2e2
LDH(IU/L) 0 249.5±58.8 304.0±33.9 278.1±45.6 259.1±54.1 259.9±53.0 252.1±51.9
10 233.9±63.8 311.8±46.7 278.1±50.7 688.7±50.7a1b1c1
465.2±62.5
a2b2c2d2
491.2±56.2
a2b2c2d2
22 246.9±67.2 218.3±48.6 155.4±41.2 628.9±16.5a2b2c1
293.7±16.2
d3
343.3±27.0
d3
TNF-α (pg/ml) 0 44.6±0.01 46.1±0.01 48.2±2.99 45.4±2.30 44.0±1.70 46.4±2.83
10 46.0±2.35 46.3±2.71 43.6±2.02 59.6±2.91 a1b1c1
49.6±2.04
c1d1
49.4±1.55
c2d1
22 44.6±2.64 46.2±2.71 48.2±2.11 66.9±4.16a1b1c1
49.8±0.20
d1
51.2±1.44
a3d1
Data is expressed as Mean ± SD (n = 6-8). Data is analysed using one-way ANOVA followed by post-hoc test. a1 P ≤ 0.001, a2 P ≤ 0.01, a3 P ≤ 0.05 
significant with respect to control group; b1 P ≤ 0.001, b2 P ≤0.01 significant with respect to Tc group; c1 P ≤ 0.001, c2 P ≤ 0.01, c3 P ≤ 0.05 significant with 
respect to Arb group; d1 P ≤ 0.001, d2 P ≤ 0.01, significant with respect to B(a)P group; e2 P ≤0.01, e3 P ≤ 0.05 significant with respect to B(a)P+ Tc group.
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death by B(a)P administration. Also, there is increasing 
evidence that TNF-α is mainly produced by cancers and 
act as an endogenous tumor promoter (49). Studies have 
shown that B(a)P administration promotes the increase of 
TNF-α levels in pulmonary tumor bearing mice (50). At 
10th week of Aq.Tc and AG treatment to cancer bearing 
animals significantly downregulated the levels of TNF-α to 
near normal values. The results of the present study are in 
collaboration with several other reports which suggested 
that T. cordifolia administration to cancer bearing mice 
downregulated the levels of TNF-α suggesting the 
Figure 6. (A) TUNEL assay performed in paraffin embedded lung/
tumor tissue sections at 200X.
a. Control, b. Benzo(a)pyrene, c. Tinospora cordifolia extract, 
d. Benzo(a)pyrene+ Tinospora cordifolia extract group, e. AG 
treated, f. Benzo(a)pyrene+ AG treated group. 
Green stained cells represent non-apoptotic cells (n), brown 
stained cells represent apoptotic cells (a). (B) Attenuation 
in apoptotic index of B(a)P induced lung tumors and its 
chemoprevention by Aq.Tc and AG.
Data is represented as mean ± SD (n= 5) and analysed by one-
way ANOVA followed by the post hoc test. Statistical significance 
and symbols: a1 P ≤ 0.001 w.rt control group; b1 P ≤0.001 w.rt B(a)
P group; c1 P ≤ 0.001  w.rt Aq.Tc group.
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immunomodulating activity of T. cordifolia extract (51). 
Surprisingly, there was no change in TNF-α levels after 
10th week of the treatment protocol in B(a)P +Aq.Tc and 
B(a)P +AG treated groups which could be because of 
higher apoptotic index found in both these groups. 
LDH is a sensitive marker for solid tumors and enhanced 
activity of this enzyme has been reported in serum 
of various lung tumor patients (52). Serum LDH was 
observed to be increased at the promotion stage (10th 
week) followed by progression stage (22nd week) of 
tumorigenesis in B(a)P treated mice which could be 
due to the increased glycolysis in cancerous conditions 
or the cellular leakage of these enzymes in circulation. 
Our results are in agreement with earlier findings which 
depicted that B(a)P administration increased the levels 
of LDH in cancer bearing animals (53). A subsequent 
decrease in LDH activity on treatment with Aq.Tc aids in 
the protection against abnormal cell growth by changing 
the permeability of membrane or by affecting the cellular 
growth of the tumor. Our lab also reported, reduction of 
pulmonary and serum levels of LDH upon administration 
of Aloe vera gel extract to cigarette smoke exposed mice 
(54). In the present study, AG administration was less 
efficient in normalising the LDH activity when compared 
to the Aq.Tc extract. AG was found to be less effective 
in protecting the membrane permeability and cellular 
proliferation of cells damaged by B(a)P insult.
CEA is one of the extensively studied tumor markers 
which has also shown prognostic value and has been found 
to overexpress on the cell surface of malignant epithelial-
type (55). It is considered as a sensitive tumor marker 
for diagnosis, prognosis, and therapy monitoring of lung 
cancer (56). Gradual increase in serum CEA levels (10th 
and 22nd week) in B(a)P installed animals was observed 
which could be associated with increase in tumor growth 
and cellular proliferation rate. Available literature also 
suggests that CEA levels increase concomitantly in lung 
tumor bearing mice (53). Reduction in levels of CEA in 
Aq.tc and AG treated animals could be due to decrease 
in tumor growth that reveal the anti-tumor effects of 
these compounds. Reduction in levels of CEA was more 
pronounced in B(a)P + Aq.Tc than B(a)P + AG group 
which shows Aq.Tc extract has more potent anticancer 
activity. An earlier finding suggested that thymoquinone, 
which is the main active constituent of black seed and 
essential oil, reduced the serum CEA levels in benzo(a)
pyrene induced lung cancer (57).
Evaluation of plasma ctDNA is a promising diagnostic and 
prognostic marker which circumvents the complications 
associated with use of invasive techniques used for 
biological sampling (58). In the present study, a spike 
in ctDNA concentration was prominent at 10th week of 
the treatment with B(a)P administration which could 
be because of the increase in necrosis of tumor cells, or 
release of the intact cells into the bloodstream and their 
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lysis. Further increase in ctDNA in lung tumor bearing 
animals at 22nd week of the treatment could be because 
of the severe progression of the tumor cells or the increase 
of micro metastatic cells in the blood, which can also shed 
their DNA into the blood circulation (59). A significant 
drop in ctDNA level was visible in Aq.Tc treated animals 
which almost reached the level observed in normal 
healthy animals. Also, in animals treated with AG, the 
drop in ctDNA level was not as striking as compared to 
Aq.Tc treated animals bearing pulmonary tumors. This 
decrease in DNA level is either because plasma DNA is 
released at lower rates or is due to rapid degrade. ctDNA 
release in blood stream could be also correlated to the 
mode of cell death as its concentration depends whether 
the cell is undergoing apoptotic cell death or necrotic 
cell death (60). Histopathological findings were also in 
concordance with altered levels of CEA, LDH, ctDNA and 
TNF-α, which showed profound increase in their levels at 
different stages of carcinogenesis. 
Conclusion: Our findings suggest that a concaminant 
increase in various tumor markers like CEA, ctDNA, 
LDH and TNF-alpha at different stages of carcinogenesis 
correlates well with the histopathological changes observed 
at early and late stages of B(a)P induced lung cancer. 
Aq.Tc successfully improved the various blood markers 
and decreased the severity of the disease as revealed by 
histopathological and other parameters. Although AG 
modulated the above mentioned parameters but Aq.Tc 
seemed to be much more effective as a chemopreventive 
agent. The histopathological findings in the present study 
are in concordance with the biochemical observations 
and are suggestive of the fact that Aq.Tc and AG have 
a potential as chemopreventive agents in pulmonary 
carcinogenesis.
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